The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Treatment patterns in patients with recurrent high-risk bladder cancer.
Eric Christian Ballon-Landa
No relevant relationships to disclose
Karim Chamie
No relevant relationships to disclose
Jeffrey C. Bassett
No relevant relationships to disclose
Timothy J. Daskivich
No relevant relationships to disclose
Julie Lai
No relevant relationships to disclose
Janet Hanley
No relevant relationships to disclose
Badrinath R. Konety
No relevant relationships to disclose
Mark S. Litwin
No relevant relationships to disclose
Christopher Saigal
No relevant relationships to disclose